Case Report

Published on 02 Jul 2024

The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report

in Hematologic Malignancies

Yueru Ji
Zhuo Wan
Jian Yang
Miaowang Hao
Li Liu
Weiwei Qin

Frontiers in Oncology

doi 10.3389/fonc.2024.1402970

1,049 views

Original Research

Published on 01 Jul 2024

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis

in Hematologic Malignancies

Blanca Xicoy
Helena Pomares
Mireia Morgades
Ulrich Germing
Montserrat Arnan
Mar Tormo
Laura Palomo
Elisa Orna
Matteo Della Porta
Felicitas Schulz

Frontiers in Oncology

doi 10.3389/fonc.2024.1385987

1,089 views

Review

Published on 01 Jul 2024

Exploring treatment decision-making in chronic myeloid leukemia in chronic phase

in Hematologic Malignancies

David Andorsky
Vamsi Kota
Kendra Sweet

Frontiers in Oncology

doi 10.3389/fonc.2024.1369246

1,691 views

Review

Published on 01 Jul 2024

Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas

in Hematologic Malignancies

Bei Hu
Victoria Korsos
M. Lia Palomba

Frontiers in Oncology

doi 10.3389/fonc.2024.1394057

1,614 views

Mini Review

Published on 28 Jun 2024

Treatment of AL amyloidosis in the era of novel immune and cellular therapies

in Hematologic Malignancies

Caitlin Sarubbi
Hesham Abowali
Cindy Varga
Heather Landau

Frontiers in Oncology

doi 10.3389/fonc.2024.1425521

2,287 views
1 citation

Original Research

Published on 25 Jun 2024

Salvage CD20-SD-CART therapy in aggressive B-cell lymphoma after CD19 CART treatment failure

in Hematologic Malignancies

Fei Xue
Peihao Zheng
Fan Yang
Rui Liu
Shaomei Feng
Yuelu Guo
Hui Shi
Lixia Ma
Biping Deng
Teng Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1376490

1,066 views

Mini Review

Published on 25 Jun 2024

Momelotinib – a promising advancement in the management of myelofibrosis in adults with anemia

in Hematologic Malignancies

Muhammad Furqan
Malik O. Oduoye

Frontiers in Oncology

doi 10.3389/fonc.2024.1411972

1,739 views

Original Research

Published on 24 Jun 2024

Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

in Hematologic Malignancies

P. Connor Johnson
Abigail Bailey
Qiufei Ma
Neil Milloy
Jake Butcher
Isaac Sanderson
Sarah Weatherby
Rachael Meadows
Ruben G. W. Quek

Frontiers in Oncology

doi 10.3389/fonc.2024.1402992

2,033 views

Review

Published on 24 Jun 2024

Multifaceted roles of IKZF1 gene, perspectives from bench to bedside

in Hematologic Malignancies

Lin Feng
Hang Zhang
Ting Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1383419

1,376 views

Original Research

Published on 24 Jun 2024

Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients

in Hematologic Malignancies

Yuxin Li
Yilin Zhang
Jin Wang
Aili He
Wanggang Zhang
Xingmei Cao
Yinxia Chen
Jie Liu
Pengyu Zhang
Jianli Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1418417

605 views

Brief Research Report

Published on 24 Jun 2024

Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience

in Hematologic Malignancies

Elisa Diral
Giulia Furnari
Alessandro Bruno
Raffaella Greco
Daniela Clerici
Sarah Marktel
Francesca Farina
Sara Mastaglio
Luca Vago
Simona Piemontese

Frontiers in Oncology

doi 10.3389/fonc.2024.1391743

1,129 views
2 citations

Original Research

Published on 21 Jun 2024

Efficacy and safety analysis of combination therapy based on mitoxantrone hydrochloride liposome injection (Lipo-MIT) in relapsed/refractory NK/T-cell lymphoma

in Hematologic Malignancies

Xing-long Wang
He-nan Wang
Lei Yang
Jing Yang
Jia Cong
Zhi-hui Song
Liang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1396819

889 views

Editorial

Published on 21 Jun 2024

Editorial: The emerging role of liquid biopsies in hematologic disorders

in Hematologic Malignancies

Ioannis Ntanasis-Stathopoulos
Daniela Drandi

Frontiers in Oncology

doi 10.3389/fonc.2024.1437621

477 views

Review

Published on 20 Jun 2024

Myelofibrosis and allogeneic transplantation: critical points and challenges

in Hematologic Malignancies

Paola Ranalli
Annalisa Natale
Francesco Guardalupi
Stella Santarone
Chiara Cantò
Gaetano La Barba
Mauro Di Ianni

Frontiers in Oncology

doi 10.3389/fonc.2024.1396435

1,653 views

Case Report

Published on 20 Jun 2024

Case report: Splenic inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS): a trial of immunotherapy and review of the literature

in Hematologic Malignancies

K. A. Resnick
C. Monroe
I. Siddiqi
E. Tam

Frontiers in Oncology

doi 10.3389/fonc.2024.1360726

707 views
1 citation

Original Research

Published on 19 Jun 2024

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

in Hematologic Malignancies

José Luis Piñana
Lourdes Vazquez
Inmaculada Heras
Tommaso Francesco Aiello
Lucia López-Corral
Ignacio Arroyo
Eva Soler-Espejo
Irene García-Cadenas
Valentín Garcia-Gutierrez
Cristina Aroca

Frontiers in Oncology

doi 10.3389/fonc.2024.1389345

1,469 views

Navigation group

Articles

The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis

Exploring treatment decision-making in chronic myeloid leukemia in chronic phase

Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas

Treatment of AL amyloidosis in the era of novel immune and cellular therapies

Salvage CD20-SD-CART therapy in aggressive B-cell lymphoma after CD19 CART treatment failure

Momelotinib – a promising advancement in the management of myelofibrosis in adults with anemia

Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey

Multifaceted roles of IKZF1 gene, perspectives from bench to bedside

Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients

Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience

Efficacy and safety analysis of combination therapy based on mitoxantrone hydrochloride liposome injection (Lipo-MIT) in relapsed/refractory NK/T-cell lymphoma

Editorial: The emerging role of liquid biopsies in hematologic disorders

Myelofibrosis and allogeneic transplantation: critical points and challenges

Case report: Splenic inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS): a trial of immunotherapy and review of the literature

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy